Centiva Capital’s Qiagen QGEN Stock Holding History

Centiva Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Sell	40,000 -10,000	-20%	-$371K	0.01%	493
2026 Q1	$2M	Buy	+50,000	New	+$2.37M	0.01%	429

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Centiva Capital's QGEN Position: Q4 2024 in Review

Centiva Capital sold out of Qiagen (QGEN) in Q4 2024, closing a stake of 10,197 shares — an estimated $478K sold.

Centiva Capital first reported a position in QGEN in Q4 2019 and held it in 8 quarters. The position peaked at $1.63M in Q3 2020. 325 funds tracked by Wall St. Rank hold QGEN as of Q4 2024.

Centiva Capital reported no remaining Qiagen position as of Q4 2024 after selling out during the quarter.
Centiva Capital sold 10,197 Qiagen shares in Q4 2024, an estimated $478K.
Centiva Capital first reported a position in Qiagen in Q4 2019 and held it in 8 quarters.
Centiva Capital's Qiagen position peaked at $1.63M in Q3 2020.
325 funds tracked by Wall St. Rank held Qiagen as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.